Eosinophilia - 48 Studies Found
Withdrawn |
: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome :
: 2005-09-28 : Drug: Gleevec |
Completed |
: Montelukast in the Treatment of Duodenal Eosinophilia :
: 2005-09-06 : Drug: montelukast |
Recruiting |
: Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index :
|
Recruiting |
: Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2002-08-24 : Drug: Imatinib Mesylate Imatinib is a tyrosine kinase inhibitor that selectively inhibits bcr-abl, c-kit |
Active, not recruiting |
: Registry for Eosinophilic Gastrointestinal Disorders (REGID) :
|
Completed |
: Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome : Hypereosinophilic Syndrome : 2001-06-15 : Drug: SCH55700 |
Completed |
: Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)? : Erosive Esophagitis : 2013-05-23 : Radiation: Esophageal Barium Xray •Fast for 4 hours |
Recruiting |
: Sponge and Eosinophil Peroxidase (EPO) Staining : Eosinophilic Esophagitis : 2017-03-08 : Device: swallowed sponge device Swallowed sponge: Subjects having a clinical upper endoscopy will be ask |